CYP450 genotype and pharmacogenetic association studies: a critical appraisal

Item

http://www.wikidata.org/entity/Q57585515

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2016

@uk

name

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

@en

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

@nl

type

Item

label

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

@en

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

@nl

prefLabel

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

@en

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

@nl

P1476

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

@en

P2093

Andrea Gaedigk

http://www.w3.org/2001/XMLSchema#string

Michel Eichelbaum

http://www.w3.org/2001/XMLSchema#string

Rashmi R Shah

http://www.w3.org/2001/XMLSchema#string

Robert L Smith

http://www.w3.org/2001/XMLSchema#string

P2860

CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug

Estimation of the warfarin dose with clinical and pharmacogenetic data.

Cellular injury and neuroinflammation in children with chronic intractable epilepsy.

Variability in drug metabolizing enzyme activity in HIV-infected patients.

CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.

CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.

Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment.

P304

259-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.15.172

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Julia C Stingl

Adrián Llerena

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26780308

http://www.w3.org/2001/XMLSchema#string